Hoda Abdel-Aty

Institute of Cancer Research

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (4)

Mick Brown

The University of Manchester

UNITED KINGDOM

View details

Joe O'Sullivan

The Queen's University Belfast

UNITED KINGDOM

View details

Silke Gillessen

The University of Manchester

UNITED KINGDOM

View details

David Matheson

reader

University of Wolverhampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hoda Abdel-Aty

Research Interests

Explore related searches

Contact this professor

Articles (9)

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

Combining Radiation Therapy With Immune Checkpoint Inhibitors for the Management of Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review From the Y-ECI ROSC EORTC Group

How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy

The quantitative impact of prostate-specific membrane antigen (PSMA) PET/CT staging in newly diagnosed metastatic prostate cancer and treatment-decision implications

The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer

Quality of Life Measurements from the Patient Perspective: Capturing the Heterogeneity of the Patient Experience in a Standardised Way

Mapping Local Failure Following Bladder Radiotherapy According to Dose

The role of radiotherapy in oligometastatic hormone-sensitive prostate cancer

Collaborators (4)

Mick Brown

Joe O'Sullivan

Silke Gillessen

David Matheson

Make your next move.